Company Filing History:
1 out of 15 
1 out of 4 Years Active: 2012
Title: Innovations of Ismael Mingarro Munoz
Introduction
Ismael Mingarro Munoz is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents against retroviral infections. His work focuses on innovative solutions to combat the human immunodeficiency virus (HIV).
Latest Patents
Ismael Mingarro Munoz holds a patent for "Non-proteolysable oligopeptides that inhibit glycoprotein GP41 of the AIDS virus." This invention relates to the identification of oligopeptides, specifically hexapeptides, that inhibit the binding of retroviruses to target cells. The D-hexapeptides identified in this patent provide novel therapies against HIV infections, particularly HIV-1. These compounds can be utilized as prophylactic or therapeutic agents, showcasing a promising avenue for HIV treatment.
Career Highlights
Throughout his career, Ismael has worked with prestigious institutions such as the Universidad del País Vasco and the Universidad de Valencia. His research has focused on the intersection of biochemistry and virology, leading to advancements in the understanding and treatment of viral infections.
Collaborations
Ismael has collaborated with notable colleagues, including Jose Luis Nieva Escandon and Maria Jose Gomara Elena. These partnerships have contributed to the success of his research and the development of innovative therapeutic solutions.
Conclusion
Ismael Mingarro Munoz's contributions to the field of biochemistry and his innovative patent for oligopeptides represent significant advancements in the fight against HIV. His work continues to inspire future research and development in the area of retroviral therapies.